Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Inhalative Doses of BI 1744 CL in Fixed Dose Combination With Tiotropium Bromide in Healthy Male Volunteers

NCT02259959 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Single rising doses of BI 1744 CL, solution for oral inhalation
DRUG: Tiotropium, fixed dose, solution for oral inhalation
DRUG: Placebo

Sponsor

Boehringer Ingelheim